- 专利标题： Cyclic dinucleotides as anticancer agents
-
申请号： US16683667申请日： 2019-11-14
-
公开(公告)号： US11339185B2公开(公告)日： 2022-05-24
- 发明人: Brian E. Fink , Dharmpal S. Dodd , Steven J. Walker , Libing Chen , Yufen Zhao , Zheming Ruan , Lan-Ying Qin , Peter Kinam Park , Muthoni G. Kamau , Lalgudi S. Harikrishnan
- 申请人： Bristol-Myers Squibb Company
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Elliott Korsen
- 主分类号： C07H19/213
- IPC分类号： C07H19/213 ; A61P35/00 ; C07H21/02 ; C07H21/00 ; C07K16/28
摘要：
The present invention is directed to compounds of the formulae I, II and III as shown below wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
公开/授权文献
- US20200079815A1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS 公开/授权日：2020-03-12
信息查询
IPC分类:
